JRCT ID: jRCT2080224901
Registered date:01/10/2019
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 03/02/2020 |
| Target sample size | 18 |
| Countries of recruitment | Japan,Asia except Japan,North America,Europe |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : - |
Outcome(s)
| Primary Outcome | safety pharmacokinetics |
|---|---|
| Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | AbbVie G.K. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT03071757,JapicCTI-194986 |